NCT02295345

Brief Summary

Despite the literature showing cognitive behavioural therapy for insomnia (CBT-I) to be effective in a variety of populations including postpartum women, as well as the demonstrated harmful consequences of sleep disturbances in late pregnancy, no trials have investigated its efficacy during pregnancy. This project will investigate the efficacy and acceptability of cognitive behavioral therapy for insomnia (CBT-I) in pregnancy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2014

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2014

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

October 23, 2014

Completed
28 days until next milestone

First Posted

Study publicly available on registry

November 20, 2014

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2015

Completed
Last Updated

September 17, 2018

Status Verified

September 1, 2018

Enrollment Period

8 months

First QC Date

October 23, 2014

Last Update Submit

September 13, 2018

Conditions

Outcome Measures

Primary Outcomes (4)

  • Change in Actigraphy indices from baseline to post-treatment

    Actigraphy is recommended as a reliable and useful method of objective sleep assessment, providing information about indices of sleep efficiency, sleep latency, total sleep time, and number and frequency of awakenings

    Baseline (Week 1), Post-treatment (Week 7)

  • Change in Sleep Diary variables from baseline to post-treatment

    Participants complete a daily, standardized sleep diary on a weekly basis both during the treatment period, and at baseline and final assessment times to corroborate actigraphy data. Dependent variables derived from this data include total sleep time, time in bed, sleep efficiency, and sleep quality

    Baseline (Week 1), Treatment (Weeks 2-6), Post-treatment (Week 7)

  • Change in Insomnia Severity Index (ISI) scores from baseline to post-treatment

    The ISI can be used to assess the severity of sleep onset, sleep maintenance and early wakening problems, sleep dissatisfaction, and one's perceived distress caused by sleep problems. Scores on the ISI range from 0 to 28, with scores ≥ 15 indicating clinical insomnia.

    Baseline (Week 1), Post-treatment (Week 7)

  • Change in Pittsburgh Sleep Quality Index (PSQI) scores from baseline to post-treatment

    The PSQI instrument is used in assessing one's sleep quality in the preceding month. It is comprised of 19 self-rated items and 5 questions rated by the roommate or bed partner. The PSQI possesses seven components: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medications and daytime dysfunction. PSQI scores range from 0 to 21, with scores greater than 5 indicating poor sleep quality.

    Baseline (Week 1), Post-treatment (Week 7)

Secondary Outcomes (1)

  • Change in Edinburgh Postpartum Depression Scale (EPDS) scores from baseline to post-treatment

    Baseline (Week 1), Post-treatment (Week 7)

Study Arms (1)

CBT for Insomnia

EXPERIMENTAL

Participants attend 5 weekly sessions of Cognitive Behavioural Therapy for Insomnia for pregnant women, administered by licensed clinical psychologist.

Other: Cognitive Behavioural Therapy for Insomnia

Interventions

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • English speaking women
  • Over the age of 18
  • Between twelve and twenty-eight weeks of gestation
  • Identify as experiencing sleep disturbances will be recruited.

You may not qualify if:

  • Women who identify as experiencing symptoms of sleep disorders other than insomnia (i.e. restless legs syndrome, obstructive sleep apnea)
  • Women who are experiencing a current major depressive episode, or have been diagnosed with bipolar disorder or other disorders that have a psychotic, dissociative, hallucinatory, or delusional component
  • Currently taking prescribed medications for sleep problems
  • Inability to attend at least 4 out of the 5 weekly therapy sessions, participate in the assessments
  • Smoking, drinking alcohol or drug use during pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Of Calgary

Calgary, Alberta, T2N1N4, Canada

Location

MeSH Terms

Conditions

Sleep Initiation and Maintenance Disorders

Interventions

Cognitive Behavioral Therapy

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Lianne Tomfohr-Madsen, PhD

    University of Calgary

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Psychology

Study Record Dates

First Submitted

October 23, 2014

First Posted

November 20, 2014

Study Start

June 1, 2014

Primary Completion

February 1, 2015

Study Completion

February 1, 2015

Last Updated

September 17, 2018

Record last verified: 2018-09

Locations